Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Ozempic, Wegovy and other new drugs are selected for Medicare’s price negotiations
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers
Ozempic could get cheaper as Medicare eyes drug price negotiations — and Novo Nordisk stock slips
The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of price negotiations, including the popular weight loss drugs Ozempic and Wegovy.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.
Ozempic, Wegovy among drugs subject to Medicare price controls
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.
fox13now3d
Xavier Becerra reflects on tenure as HHS secretary: 'We're leaving this country is healthier and stronger'
Xavier Becerra, the outgoing Health and Human Services secretary, says the country is "healthier and stronger" than when he took office in 2021, during the peak of the COVID-19 pandemic.
Becerra, With No Regrets, Defends Vaccine Mandates and Misinformation Fight
In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...
Politico4d
Becerra lauds his tenure
BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra ... is returning as CMS chief operating officer. — Drew Snyder is expected ...
Fierce Healthcare11d
23.6M people have signed up for ACA coverage during open enrollment: CMS
More than 23 million people have selected coverage on the Affordable Care Act's exchange as part of open enrollment, ...
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.
The Washington Post8d
‘I can’t go toe to toe with social media.’ Top U.S. health official reflects, regrets.
As they entered office at the height of the coronavirus pandemic in early 2021, Xavier Becerra and his allies had a plan to restore Americans’ faith in the nation’s beleaguered public health ...
Obamacare’s 24.2 Million Enrollment Breaks Record As Biden Exits
The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act ...
AOL3d
Xavier Becerra reflects on tenure as HHS secretary: 'We're leaving this country healthier and stronger'
Xavier Becerra, the outgoing Health and Human Services secretary, says the country is "healthier and stronger" than when he took office in 2021, during the peak of the COVID-19 pandemic.